Company Filing History:

8 out of 712

The Rockefeller University

patents

1 out of 27

The Rockfeller University

5. 1 out of 832,812

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2016

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9447454 - Method of purifying RNA binding protein-RNA complexes (2016-09-20),

2. 9175039 - Methods and compositions for tumor vaccination and therapy (2015-11-03),

3. 8541547 - Methods and compositions for tumor vaccination and therapy (2013-09-24),

4. 8193313 - Methods and compositions for tumor vaccination and therapy (2012-06-05),

5. 7989203 - Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells (2011-08-02),

6. 7928190 - Methods and compositions for tumor vaccination and therapy (2011-04-19),

7. 7432052 - Method and identification of downstream mRNA ligands to FMRP and their role in fragile X syndrome and associated disorders (2008-10-07),

8. 7129037 - Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells (2006-10-31),

9. 6750029 - Methods and agents for the detection and modulation of cellular immunity to immune privileged antigens (2004-06-15),

10. 6602709 - Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells (2003-08-05),

Title: Innovations and Contributions of Inventor Robert Darnell

Introduction

Robert Darnell is a prominent inventor based in Pelham, NY (US), known for his significant contributions to the field of molecular biology. He holds a total of 10 patents, showcasing his innovative approach to scientific challenges. His work primarily focuses on RNA binding proteins and cancer immunotherapy.

Latest Patents

One of Darnell's latest patents is titled "Method of purifying RNA binding protein-RNA complexes." This invention provides methods for purifying RNA molecules that interact with RNA binding proteins (RBPs). It also includes sequences of RNA molecules that mediate binding to RBPs, proteins encoded by these sequences, and methods for identifying these sequences. Additionally, the invention outlines the use of these sequences in screening for bioactive molecules and provides methods for treating diseases associated with RBP functions.

Another notable patent is "Methods and compositions for tumor vaccination and therapy." This invention relates to peptide vaccines and pharmaceutical compositions that promote immune-mediated regression of tumors expressing onconeural antigens. The cancer peptide vaccines are designed to be presented on the MHC I complex of target cells, promoting a specific cytotoxic T lymphocyte (CTL)-mediated immune response against tumor cells. This innovative approach aims to induce immunological reactivity against cancer.

Career Highlights

Throughout his career, Robert Darnell has worked with esteemed institutions, including The Rockefeller University. His research has significantly advanced the understanding of RNA interactions and cancer therapies, making him a key figure in his field.

Collaborations

Darnell has collaborated with notable scientists, including Nina Bhardwaj and Ralph M. Steinman. These collaborations have further enriched his research and contributed to the development of innovative solutions in molecular biology and cancer treatment.

Conclusion

Robert Darnell's contributions to science through his patents and collaborations highlight his role as a leading inventor in the field of molecular biology. His innovative methods and approaches continue to influence research and therapeutic strategies in cancer treatment and RNA biology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com